Biperiden hydrochloride (Akineton 2 mg Tablet) and Buprenorphine: interaction and safety
This source-based reference is not a personal treatment recommendation. The relevance and management of an interaction depend on the exact products, route, dose and clinical situation.
Interaction mechanism
Additive reduction in gastrointestinal and bladder motility.
Clinical significance and safety
Biperiden can add to opioid-related constipation or urinary retention, occasionally contributing to severe reduction of bowel movement or paralytic ileus. The prescriber should review the combination and monitor for the effects described; do not adjust the opioid or the other medicine independently.
Using this information
This is a source-based reference record, not a recommendation to combine, stop or change medicines. A missing interaction record does not establish safe use. A qualified healthcare professional should consider the exact products, doses, other medicines and individual health circumstances.